Blood Purification Devices Market By Product Type (Hemodialysis Device, Blood Filtration Device, Continuous Renal Replacement Therapy (CRRT) Device, Hemoperfusion Device, Plasma Exchange Device), By Type (Portable And Stationary), By Application (Diagnostics And Therapeutics) By End User (Hospitals, Dialysis Centres And Others), By Geography is expected to grow at a steady CAGR Forecast till 2026 owing to an Increase In the number of cases for Hypertension and the Rise Observed in the Chronic Kidney Disease (CKD) and End Stage Renal Disease Patients
Global Blood Purification Devices Market was valued at USD 4.71 billion in 2020, growing at a CAGR of 4.18% during the forecast period from 2021 to 2026, to reach USD 5.33 billion by 2026. The demand for blood purification devices is primarily witnessing growth on account of the increase in number of Chronic Kidney diseases (CKD) and End Stage Renal Disease (ESRD) patients, surge in the cases of hypertension and diabetes leading to kidney disorders, technological advancements in hemodialysis, increasing product approvals by FDA and increase in adoption of blood purification equipment.
The rising number of patients suffering from Chronic Kidney diseases (CKD) and End Stage Renal Disease (ESRD) is one of the major reasons for driving the Blood Purification Devices market. According to the research paper “Chronic Kidney Disease is on the Rise”, by Haileamlak et al. in 2018, chronic disease tends to affect about 10% of the world’s adult population. Several conditions comprising of diabetes, hypertension, vascular disease and glomerulonephritis are known to cause the Chronic Renal Disease. Even in low-income countries, besides the above known causes, glomerulonephritis and interstitial nephritis are the major cause for most of the chronic kidney disease due to the high prevalence of infections. According to this research although CKD tends to affect certain age groups and sexes, it is more prevalent in case of aged individuals. As per the previous source, it is estimated that the worldwide prevalence of CKD is 23–36% in people aged ≥64.
As per the statistics of Chronic Kidney Disease in the United States, 2021, more than 1 in 7 i.e. 15% of US adults or 37 million people, are estimated to have CKD. It is more commonly seen in people aged 65 years or older (38%) than in people aged 45–64 years (12%) or 18–44 years (6%). The disease is slightly more common in women (14%) than men (12%). 1 in 3 adults (approximately 80 million adults) are at the risk of kidney disease. Due to the rise in the number of CKD and ESRD patients, there will be a high demand observed for blood purification devices, leading to a boost in the blood purification devices market.
However, the high cost of blood purification equipment and the risks associated with the blood purification procedures are expected to limit the market growth over the forecast period.
Blood Purification Devices market by Product Type (Hemodialysis Device, Blood Filtration Device, Continuous Renal Replacement Therapy (CRRT) Device, Hemoperfusion Device, Plasma Exchange Device), By Type (Portable and Stationary), By Application (Diagnostics and Therapeutics), Blood Purification Devices market by End User (Hospitals, Dialysis Centers and Others), and Blood Purification Devices market by Geography (North America, Europe, Asia-Pacific, and Rest of the World).
Depending on type, the Blood Purification Devices market can be segmented into portable and stationary blood purification devices. The portable blood purification devices can be anticipated to be the largest growing segment in the market. The reason being the advantages that are offered by the portable type of blood purification devices such as less utilization of space and ease related to movement of the devices, specifically in critical care units. Therefore, these are most likely preferred by healthcare professionals for the treatment of patients.
Portable blood purification devices can potentially improve the quality of patient life by allowing them to continue with their daily activities of life while undergoing dialysis as well as by loosening—or removing entirely—dietary and fluid restrictions and reducing pill burden. For instance, on March 12, 2021, Baxter had announced the United States approval of the AK 98 Hemodialysis Machine. The latest technology provides a compact, portable and easy-to-use system for the dialysis providers. The machine has a stable base design which allows for easy concentrate or portable reverse osmosis storage and transportation with the machine. Due to the approval of such devices, the demand for portable devices is expected to rise in future as they tend to offer better results in comparison to the stationary blood purification devices. This will lead to the growth of the portable blood purification devices market.
Among all the regions, North America is expected to account for the largest share in the blood purification devices market. The rising prevalence of Chronic Kidney Disease and End Stage Renal Diseases among Americans along with the increasing awareness among patients for blood purification devices and the well-established healthcare infrastructure are predicted to be the major influencing factors in driving the overall growth of the market over the forecast period.
As per the statistics of Chronic Kidney Disease in the United States, 2021, CKD is more commonly seen in people that are above the age of 65 years or older than in people aged 45–64 years (12%) or 18–44 years (6%). Also, according to the United States Renal Data System 2020 Annual Report, overall, 14.9% of the U.S. adult population surveyed in 2015-2018 had CKD based on a low eGFR or proteinuria (on a single examination). As per the same organization in 2019 Annual Report, the number of prevalent ESRD cases has continued to rise by about 20,000 cases per year. In the North American region, an increasing number of people are suffering from kidney failure problems due to chronic kidney diseases. Therefore, this situation will help the market to expand further, fueling the blood purification equipment.
Some of the key market players operating in the Blood Purification Devices market includes Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International Inc., Fresenius SE and Co. KGaA, Infomed SA, Jafron Biomedical Co., Ltd., Kaneka Corporation, Nikkiso Co, ltd. and SWS Medical Group, CytoSorbents Europe GmbH, Spectral Medical Inc., Haemonetics Corporation, Medtronic, Cerus Corporation, ExThera Medical Corporation and others.
What is Blood Purification Devices?
Blood Purification is a procedure which involves withdrawal of blood from the patient’s body into a device or an equipment in order to eliminate the impurities and pump it back into the body. The blood purification devices are similar to that of dialysis equipment. These device use thin fibres for capturing and removing viruses and helps in filtering the blood.
What is the market for Global Blood Purification Devices?
Global Blood Purification Devices Market was valued at USD 4.71 billion in 2020, growing at a CAGR of 4.18% during the forecast period from 2021 to 2026, to reach USD 5.33 billion by 2026.
What are the drivers for Global Blood Purification Devices?
The major drivers driving the demand for Global Blood Purification Devices are the increase in the number of chronic kidney disease and end stage renal disease patients, increasing number of cases of hypertension and diabetes leading to kidney disorders, technological advancements in hemodialysis, rise in the number of product approvals by FDA and increase in adoption of blood purification equipment .
What are the key players operating in Global Blood Purification Devices?
Some of the key market players operating in the Diagnostic Imaging Equipment market includes Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International Inc., Fresenius SE and Co. KGaA, Infomed SA, Jafron Biomedical Co., Ltd., Kaneka Corporation, and others.
What regions has the highest share in Blood Purification Devices market?
North America is expected to dominate the overall Blood Purification Devices during the forecast period, 2021 to 2026. This domination is due to the rising prevalence of CKD and ESRD in patients along with the increased awareness regarding blood purification devices and the rapid expansion of healthcare infrastructure.
1. Blood Purification Devices Report Introduction
2. Blood Purification Devices Executive summary
2.1. Scope of the Study
2.2. Market at Glance
2.3. Competitive Assessment
2.4. Financial Benchmarking
3. Regulatory and Patent Analysis
3.1. The United States
3.2. Europe
3.2.1. Germany
3.2.2. France
3.2.3. Italy
3.2.4. Spain
3.2.5. U.K.
3.3. Japan
4. Blood Purification Devices Key Factors Analysis
4.1. Blood Purification Devices Market Drivers
4.1.1. Increase in number of Chronic Kidney diseases (CKD) and End Stage Renal Disease (ESRD) patients
4.1.2. Surge in the cases of hypertension and diabetes leading to kidney disorders
4.1.3. Technological advancements in hemodialysis
4.1.4. Increasing product approvals by FDA
4.1.5. And increase in adoption of blood purification equipment
4.2. Blood Purification Devices Market Restraints and Challenges
4.2.1. High cost of Blood Purification Devices
4.2.2. Risks associated with the blood purification procedures
4.3. Blood Purification Devices Market Opportunities
4.3.1. Blood Purification Devices have applications in various domains
5. Blood Purification Devices Porter’s Five Forces Analysis
5.1. Bargaining Power of Suppliers
5.2. Bargaining Power of Consumers
5.3. Threat of New Entrants
5.4. Threat of Substitutes
5.5. Competitive Rivalry
6. COVID-19 Impact Analysis on Blood Purification Devices Market
7. Blood Purification Devices Market Layout
7.1. By Product Type
7.1.1. Hemodialysis Device
7.1.2. Blood Filtration Device
7.1.3. Continuous Renal Replacement Therapy (CRRT) Device
7.1.4. Hemoperfusion Device
7.1.5. Plasma Exchange Device
7.2. By Type
7.2.1. Stationary
7.2.2. Portable
7.3. By End User
7.3.1. Hospitals
7.4.2. Diagnostic Centers
7.4.3. Others
7.4. By Geography
7.4.1. North America
7.4.1.1. North America Blood Purification Devices Market, by Product Type
7.4.1.2. North America Blood Purification Devices Market, by Type
7.4.1.3. North America Blood Purification Devices Market, by End User
7.4.1.4. North America Blood Purification Devices Market, by Country
7.5.1.4.1. United States
7.5.1.4.2. Canada
7.5.1.4.3. Mexico
7.5.2. Europe
7.5.2.1. Europe Blood Purification Devices Market, by Product Type
7.5.2.2. Europe Blood Purification Devices Market, by Type
7.5.2.3. Europe Blood Purification Devices Market, by End User
7.5.2.4. Europe Blood Purification Devices Market, by Country
7.5.2.4.1. France
7.5.2.4.2. Germany
7.5.2.4.3. United Kingdom
7.5.2.4.4. Italy
7.5.2.4.5. Spain
7.5.2.4.6. Russia
7.5.2.4.7. Rest of Europe
7.5.3. Asia-Pacific
7.5.3.1. Asia-Pacific Blood Purification Devices Market, by Product Type
7.5.3.2. Asia-Pacific Blood Purification Devices Market, by Type
7.5.3.3. Asia-Pacific Blood Purification Devices Market, by End User
7.5.3.4. Asia-Pacific Blood Purification Devices Market, by Country
7.5.4.5.1. China
7.5.4.5.2. Japan
7.5.4.5.3. India
7.5.4.5.4. Australia
7.5.4.5.5. South Korea
7.5.4.5.6. Rest of Asia Pacific
7.5.4. Rest of the World (RoW)
7.5.4.1. RoW Blood Purification Devices Market, by Product Type
7.5.4.2. RoW Blood Purification Devices Market, by Type
7.5.4.3. RoW Blood Purification Devices Market, by End User
7.5.4.4. RoW Blood Purification Devices Market, by Region
7.5.4.4.1. Middle East
7.5.4.4.2. Africa
7.5.4.4.3. South America
8. Blood Purification Devices Global Company Share Analysis – Key 3-5 Companies
9. Blood Purification Devices Company and Product Profiles
9.1. Asahi Kasei Corporation
9.1.1. Company Overview
9.1.2. Company Snapshot
9.1.3. Financial Overview
9.1.4. Product Listing
9.1.5. Entropy
9.2. B. Braun Melsungen AG
9.2.1. Company Overview
9.2.2. Company Snapshot
9.2.3. Financial Overview
9.2.4 Product Listing
9.2.5. Entropy
9.3. Fresenius SE and Co. KGaA
9.3.1. Company Overview
9.3.2. Company Snapshot
9.3.3. Financial Overview
9.3.4 Product Listing
9.3.5. Entropy
9.4. Baxter International Inc.,
9.4.1. Company Overview
9.4.2. Company Snapshot
9.4.3. Financial Overview
9.4.4 Product Listing
9.4.5. Entropy
9.5. Infomed SA
9.5.1. Company Overview
9.5.2. Company Snapshot
9.5.3. Financial Overview
9.5.4 Product Listing
9.5.5. Entropy
9.6. Jafron Biomedical Co., Ltd.
9.6.1. Company Overview
9.6.2. Company Snapshot
9.6.3. Financial Overview
9.6.4 Product Listing
9.6.5. Entropy
9.7. Kaneka Corporation
9.7.1. Company Overview
9.7.2. Company Snapshot
9.7.3. Financial Overview
9.7.4 Product Listing
9.7.5. Entropy
9.8. Nikkiso Co, ltd.
9.8.1. Company Overview
9.8.2. Company Snapshot
9.8.3. Financial Overview
9.8.4 Product Listing
9.8.5. Entropy
9.9. SWS Medical Group
9.9.1. Company Overview
9.9.2. Company Snapshot
9.9.3. Financial Overview
9.9.4 Product Listing
9.9.5. Entropy
9.10. Medtronic, Inc.
9.10.1. Company Overview
9.10.2. Company Snapshot
9.10.3. Financial Overview
9.10.4 Product Listing
9.10.5. Entropy
9.11. CytoSorbents Europe GmbH
9.11.1. Company Overview
9.11.2. Company Snapshot
9.11.3. Financial Overview
9.11.4 Product Listing
9.11.5. Entropy
9.12. Spectral Medical Inc
9.12.1. Company Overview
9.12.2. Company Snapshot
9.12.3. Financial Overview
9.12.4 Product Listing
9.12.5. Entropy
9.13. Haemonetics Corporation
9.13.1. Company Overview
9.13.2. Company Snapshot
9.13.3. Financial Overview
9.13.4 Product Listing
9.13.5. Entropy
9.14. Ceus Corporation
9.14.1. Company Overview
9.14.2. Company Snapshot
9.14.3. Financial Overview
9.14.4 Product Listing
9.14.5. Entropy
9.15. ExThera Medical Corporation
9.15.1. Company Overview
9.15.2. Company Snapshot
9.15.3. Financial Overview
9.15.4 Product Listing
9.15.5. Entropy
10. Project Approach
10.1. Secondary Sources
10.2. Primary Sources
10.3. Data Triangulation
10.4. Key Expert Opinions
11. KOL Views
12. DelveInsight Capabilities
13. Disclaimer
14. About DelveInsight
List of Table
Table 1: Competitive Analysis
Table 2: COVID-19 Impact Analysis
Table 3: Blood Purification Devices in Global (2018-2026)
Table 4: Blood Purification Devices in Global by Type (2018-2026)
Table 5: Blood Purification Devices in Global by Product Type (2018-2026)
Table 6: Blood Purification Devices in Global by End User (2018-2026)
Table 7: Blood Purification Devices in Global by Geography (2018-2026)
Table 8: Blood Purification Devices in North America (2018-2026)
Table 9: Blood Purification Devices in North America by Type (2018-2026)
Table 10: Blood Purification Devices in North America by Product Type (2018-2026)
Table 11: Blood Purification Devices in North America by End User (2018-2026)
Table 12: Blood Purification Devices in North America by Country (2018-2026)
Table 13: Blood Purification Devices in the US (2018-2026)
Table 14: Blood Purification Devices in Canada (2018-2026)
Table 15: Blood Purification Devices in Mexico (2018-2026)
Table 16: Blood Purification Devices in Europe (2018-2026)
Table 17: Blood Purification Devices in Europe by Type (2018-2026)
Table 18: Blood Purification Devices in Europe by Product Type (2018-2026)
Table 19: Blood Purification Devices in Europe by End User (2018-2026)
Table 20: Blood Purification Devices in Europe by Country (2018-2026)
Table 21: Blood Purification Devices in France (2018-2026)
Table 22: Blood Purification Devices in Germany (2018-2026)
Table 23: Blood Purification Devices in UK (2018-2026)
Table 24: Blood Purification Devices in Italy (2018-2026)
Table 25: Blood Purification Devices in Spain (2018-2026)
Table 26: Blood Purification Devices in Russia (2018-2026)
Table 27: Blood Purification Devices in Rest of Europe (2018-2026)
Table 28: Blood Purification Devices in Asia Pacific (2018-2026)
Table 29: Blood Purification Devices in Asia Pacific by Type (2018-2026)
Table 30: Blood Purification Devices in Asia Pacific by Product Type (2018-2026)
Table 31: Blood Purification Devices in Asia Pacific by End User (2018-2026)
Table 32: Blood Purification Devices in Asia Pacific by Country (2018-2026)
Table 33: Blood Purification Devices in China (2018-2026)
Table 34: Blood Purification Devices in Japan (2018-2026)
Table 35: Blood Purification Devices in India (2018-2026)
Table 36: Blood Purification Devices in Australia (2018-2026)
Table 37: Blood Purification Devices in South Korea (2018-2026)
Table 38: Blood Purification Devices in Rest of Asia Pacific (2018-2026)
Table 39: Blood Purification Devices in Rest of the World (2018-2026)
Table 40: Blood Purification Devices in Rest of the World by Type (2018-2026)
Table 41: Blood Purification Devices in Rest of the World by Product Type (2018-2026)
Table 42: Blood Purification Devices in Rest of the World by End User (2018-2026)
Table 43: Blood Purification Devices in Rest of the World by Country (2018-2026)
Table 44: Blood Purification Devices in Middle East (2018-2026)
Table 45: Blood Purification Devices in Africa (2018-2026)
Table 46: Blood Purification Devices in South America (2018-2026)
List of Figures
Figure 1: Competitive Analysis
Figure 2: COVID-19 Impact Analysis
Figure 3: Blood Purification Devices in Global (2018-2026)
Figure 4: Blood Purification Devices in Global by Type (2018-2026)
Figure 5: Blood Purification Devices in Global by Product Type (2018-2026)
Figure 6: Blood Purification Devices in Global by End User (2018-2026)
Figure 7: Blood Purification Devices in Global by Geography (2018-2026)
Figure 8: Blood Purification Devices in North America (2018-2026)
Figure 9: Blood Purification Devices in North America by Type (2018-2026)
Figure 10: Blood Purification Devices in North America by Product Type (2018-2026)
Figure 11: Blood Purification Devices in North America by End User (2018-2026)
Figure 12: Blood Purification Devices in North America by Country (2018-2026)
Figure 13: Blood Purification Devices in the US (2018-2026)
Figure 14: Blood Purification Devices in Canada (2018-2026)
Figure 15: Blood Purification Devices in Mexico (2018-2026)
Figure 16: Blood Purification Devices in Europe (2018-2026)
Figure 17: Blood Purification Devices in Europe by Type (2018-2026)
Figure 18: Blood Purification Devices in Europe by Product Type (2018-2026)
Figure 19: Blood Purification Devices in Europe by End User (2018-2026)
Figure 20: Blood Purification Devices in Europe by Country (2018-2026)
Figure 21: Blood Purification Devices in France (2018-2026)
Figure 22: Blood Purification Devices in Germany (2018-2026)
Figure 23: Blood Purification Devices in UK (2018-2026)
Figure 24: Blood Purification Devices in Italy (2018-2026)
Figure 25: Blood Purification Devices in Spain (2018-2026)
Figure 26: Blood Purification Devices in Russia (2018-2026)
Figure 27: Blood Purification Devices in Rest of Europe (2018-2026)
Figure 28: Blood Purification Devices in Asia Pacific (2018-2026)
Figure 29: Blood Purification Devices in Asia Pacific by Type (2018-2026)
Figure 30: Blood Purification Devices in Asia Pacific by Product Type (2018-2026)
Figure 31: Blood Purification Devices in Asia Pacific by End User (2018-2026)
Figure 32: Blood Purification Devices in Asia Pacific by Country (2018-2026)
Figure 33: Blood Purification Devices in China (2018-2026)
Figure 34: Blood Purification Devices in Japan (2018-2026)
Figure 35: Blood Purification Devices in India (2018-2026)
Figure 36: Blood Purification Devices in Australia (2018-2026)
Figure 37: Blood Purification Devices in South Korea (2018-2026)
Figure 38: Blood Purification Devices in Rest of Asia Pacific (2018-2026)
Figure 39: Blood Purification Devices in Rest of the World (2018-2026)
Figure 40: Blood Purification Devices in Rest of the World by Type (2018-2026)
Figure 41: Blood Purification Devices in Rest of the World by Product Type (2018-2026)
Figure 42: Blood Purification Devices in Rest of the World by End User (2018-2026)
Figure 43: Blood Purification Devices in Rest of the World by Country (2018-2026)
Figure 44: Blood Purification Devices in Middle East (2018-2026)
Figure 45: Blood Purification Devices in Africa (2018-2026)
Figure 46: Blood Purification Devices in South America (2018-2026)
Figure 47: Market Drivers
Figure 48: Market Barriers
Figure 49: Market Opportunities
Figure 50: PORTER'S Five Force Analysis
Asahi Kasei Corporation
B. Braun Melsungen AG
Baxter International Inc.
Fresenius SE and Co. KGaA
Infomed SA
Jafron Biomedical Co., Ltd.
Kaneka Corporation
